Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Blackstone
BX
|
$404M |
| 2 |
Uber
UBER
|
$319M |
| 3 |
Bristol-Myers Squibb
BMY
|
$316M |
| 4 |
Danaher
DHR
|
$302M |
| 5 |
Honeywell
HON
|
$281M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$812M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
$701M |
| 3 |
AGN
Allergan plc
AGN
|
$629M |
| 4 |
Humana
HUM
|
$380M |
| 5 |
Bank of America
BAC
|
$290M |
Sector Composition
| 1 | Technology | 24.72% |
| 2 | Healthcare | 17.4% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 11.3% |
| 5 | Consumer Discretionary | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vertex Pharmaceuticals
VRTX
$102B
| $193M | 0.1% |
1,049,936
+283,447
| +37% | +$52M |
|
227
Ryanair
RYAAY
$32.1B
| $191M | 0.1% |
7,449,493
+1,509,345
| +25% | +$38.7M |
|
228
NCR Voyix
VYX
$1.84B
| $190M | 0.1% |
9,941,574
+293,777
| +3% | +$5.61M |
|
|
SUM
229
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $189M | 0.1% |
9,998,415
+742,803
| +8% | +$14.1M |
|
230
S&P Global
SPGI
$164B
| $187M | 0.1% |
819,772
+241,848
| +42% | +$55.1M |
|
|
TSS
231
DELISTED
Total System Services, Inc.
TSS
| $185M | 0.1% |
1,443,403
-409,082
| -22% | -$52.5M |
|
232
OSI Systems
OSIS
$3.93B
| $183M | 0.1% |
1,620,673
-67,885
| -4% | -$7.65M |
|
233
Rogers Corp
ROG
$1.43B
| $182M | 0.1% |
1,055,376
-40,622
| -4% | -$7.01M |
|
234
Integra LifeSciences
IART
$1.25B
| $181M | 0.1% |
3,248,870
+375,546
| +13% | +$21M |
|
|
EQC
235
DELISTED
Equity Commonwealth
EQC
| $181M | 0.1% |
5,574,448
-172,622
| -3% | -$5.61M |
|
236
Liberty Broadband Class C
LBRDK
$8.61B
| $181M | 0.1% |
1,738,966
-52,861
| -3% | -$5.51M |
|
237
Equinix
EQIX
$75.7B
| $180M | 0.1% |
356,381
+95,141
| +36% | +$48M |
|
238
AnaptysBio
ANAB
$613M
| $179M | 0.1% |
3,181,439
-98,192
| -3% | -$5.54M |
|
239
Dollar Tree
DLTR
$20.6B
| $179M | 0.1% |
1,669,173
-104,412
| -6% | -$11.2M |
|
240
Walmart
WMT
$801B
| $179M | 0.1% |
4,854,294
-476,412
| -9% | -$17.5M |
|
241
Exxon Mobil
XOM
$466B
| $178M | 0.1% |
2,321,974
+87,354
| +4% | +$6.69M |
|
242
Entergy
ETR
$39.2B
| $177M | 0.1% |
3,447,472
+475,710
| +16% | +$24.5M |
|
243
Ligand Pharmaceuticals
LGND
$3.25B
| $176M | 0.1% |
2,472,900
+252,639
| +11% | +$18M |
|
244
Nordson
NDSN
$12.6B
| $175M | 0.09% |
1,234,900
+11,014
| +0.9% | +$1.56M |
|
|
MRTX
245
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $173M | 0.09% |
1,677,539
-357,205
| -18% | -$36.8M |
|
246
Copart
CPRT
$47B
| $172M | 0.09% |
9,222,016
-1,177,612
| -11% | -$22M |
|
247
Visteon
VC
$3.41B
| $171M | 0.09% |
2,925,896
-5,116
| -0.2% | -$300K |
|
248
Church & Dwight Co
CHD
$23.3B
| $171M | 0.09% |
2,335,916
+74,070
| +3% | +$5.41M |
|
249
Bruker
BRKR
$4.68B
| $167M | 0.09% |
3,335,079
+36,643
| +1% | +$1.83M |
|
250
Guidewire Software
GWRE
$22B
| $166M | 0.09% |
1,636,460
+122,416
| +8% | +$12.4M |
|